Non-melanoma skin cancer
What is skin cancer?
Skin cancer starts in the cells of the skin. The most common types of skin cancer are basal cell carcinoma, squamous cell carcinoma and melanoma.
Risk factors for non-melanoma skin cancer
Risk factors for non-melanoma skin cancer include sun and ultraviolet radiation and having a fair complexion. Learn about non-melanoma skin cancer risk.
Finding skin cancer early
When non-melanoma is found early the chances of successful treatment are better. Learn what puts you at high risk for skin cancer and symptoms to watch for.
Signs and symptoms of non-melanoma skin cancer
Common signs and symptoms of non-melanoma skin cancer include a sore that doesn't heal, a sore that bleeds and scaly red patches on the skin.
Diagnosis of non-melanoma skin cancer
Non-melanoma skin cancer can be diagnosed or ruled out by such tests as health history and skin biopsy.
Grading non-melanoma skin cancer
The grade describes how cancer cells look and act compared to normal cells. Low-grade non-melanoma skin cancer tends to grow more slowly and is less likely to spread than high-grade non-melanoma skin cancer.
Stages of non-melanoma skin cancer
Staging describes how much cancer is in the body.
If non-melanoma skin cancer spreads
Most non-melanoma skin cancers don't spread to other parts of the body. If they do, they can spread to nearby lymph nodes, lungs or bone.
Prognosis and survival for non-melanoma skin cancer
Prognosis estimates the outcome for non-melanoma skin cancer. It depends on many factors including the location, size and depth of the cancer.
Treatments for non-melanoma skin cancer
Non-melanoma skin cancer can be treated with surgery, radiation therapy, drug therapy and photodynamic therapy.
Supportive care for skin cancer
Supportive care for non-melanoma skin cancer and melanoma skin cancer helps people meet physical, practical, emotional and spiritual challenges.
Non-melanoma skin cancer statistics
Non-melanoma skin cancer is the most commonly diagnosed cancer in Canada. Learn about statistics for non-melanoma skin cancer.